Literature DB >> 26423941

Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Sarah L Londrigan1, Kirsty R Short1, Joel Ma1, Leah Gillespie1, Steven P Rockman2, Andrew G Brooks1, Patrick C Reading3.   

Abstract

UNLABELLED: Airway epithelial cells are susceptible to infection with seasonal influenza A viruses (IAV), resulting in productive virus replication and release. Macrophages (MΦ) are also permissive to IAV infection; however, virus replication is abortive. Currently, it is unclear how productive infection of MΦ is impaired or the extent to which seasonal IAV replicate in MΦ. Herein, we compared mouse MΦ and epithelial cells for their ability to support genomic replication and transcription, synthesis of viral proteins, assembly of virions, and release of infectious progeny following exposure to genetically defined IAV. We confirm that seasonal IAV differ in their ability to utilize cell surface receptors for infectious entry and that this represents one level of virus restriction. Following virus entry, we demonstrate synthesis of all eight segments of genomic viral RNA (vRNA) and mRNA, as well as seven distinct IAV proteins, in IAV-infected mouse MΦ. Although newly synthesized hemagglutinin (HA) and neuraminidase (NA) glycoproteins are incorporated into the plasma membrane and expressed at the cell surface, electron microscopy confirmed that virus assembly was defective in IAV-infected MΦ, defining a second level of restriction late in the virus life cycle. IMPORTANCE: Seasonal influenza A viruses (IAV) and highly pathogenic avian influenza viruses (HPAI) infect macrophages, but only HPAI replicate productively in these cells. Herein, we demonstrate that impaired virus uptake into macrophages represents one level of restriction limiting infection by seasonal IAV. Following uptake, seasonal IAV do not complete productive replication in macrophages, representing a second level of restriction. Using murine macrophages, we demonstrate that productive infection is blocked late in the virus life cycle, such that virus assembly is defective and newly synthesized virions are not released. These studies represent an important step toward identifying host-encoded factors that block replication of seasonal IAV, but not HPAI, in macrophages.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26423941      PMCID: PMC4665238          DOI: 10.1128/JVI.01455-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA.

Authors:  John F Regan; Yuying Liang; Tristram G Parslow
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Abortive infection of Vero cells by an influenza A virus (FPV).

Authors:  S C Lau; C Scholtissek
Journal:  Virology       Date:  1995-09-10       Impact factor: 3.616

3.  Biosynthesis of the influenza virus envelope in abortive infection.

Authors:  J Lohmeyer; L T Talens; H D Klenk
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

4.  Generation of influenza A viruses entirely from cloned cDNAs.

Authors:  G Neumann; T Watanabe; H Ito; S Watanabe; H Goto; P Gao; M Hughes; D R Perez; R Donis; E Hoffmann; G Hobom; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

5.  Involvement of the mannose receptor in infection of macrophages by influenza virus.

Authors:  P C Reading; J L Miller; E M Anders
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Universal primer set for the full-length amplification of all influenza A viruses.

Authors:  E Hoffmann; J Stech; Y Guan; R G Webster; D R Perez
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

Review 7.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

8.  Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro.

Authors:  M A Wells; P Albrecht; S Daniel; F A Ennis
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  Interaction of influenza virus with mouse macrophages.

Authors:  B Rodgers; C A Mims
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

10.  The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm.

Authors:  Han Xiao; Marian J Killip; Peter Staeheli; Richard E Randall; David Jackson
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

View more
  20 in total

1.  Bacterial Outer Membrane Vesicles Provide Broad-Spectrum Protection against Influenza Virus Infection via Recruitment and Activation of Macrophages.

Authors:  Eun-Hye Bae; Sang Hwan Seo; Chang-Ung Kim; Min Seong Jang; Min-Suk Song; Tae-Young Lee; Yu-Jin Jeong; Moo-Seung Lee; Jong-Hwan Park; Pureum Lee; Young Sang Kim; Sang-Hyun Kim; Doo-Jin Kim
Journal:  J Innate Immun       Date:  2019-03-07       Impact factor: 7.349

2.  Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.

Authors:  Shauna A Marvin; Marion Russier; C Theodore Huerta; Charles J Russell; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

3.  A Glu-Glu-Tyr Sequence in the Cytoplasmic Tail of the M2 Protein Renders Influenza A Virus Susceptible to Restriction of the Hemagglutinin-M2 Association in Primary Human Macrophages.

Authors:  Sukhmani Bedi; Rajat Mudgal; Amanda Haag; Akira Ono
Journal:  J Virol       Date:  2022-09-13       Impact factor: 6.549

4.  Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression In Vitro and Prevents Lesion Formation in the Mouse Zosteriform Model.

Authors:  Melkamu B Tessema; Rubaiyea Farrukee; Christopher E Andoniou; Mariapia A Degli-Esposti; Clare V Oates; James B Barnes; Linda M Wakim; Andrew G Brooks; Sarah L Londrigan; Patrick C Reading
Journal:  J Virol       Date:  2022-05-31       Impact factor: 6.549

5.  Duvira Antarctic polysaccharide inhibited H1N1 influenza virus-induced apoptosis through ROS mediated ERK and STAT-3 signaling pathway.

Authors:  Jingyao Su; Danyang Chen; Ruilin Zheng; Xia Liu; Mingqi Zhao; Bing Zhu; Yinghua Li
Journal:  Mol Biol Rep       Date:  2022-04-12       Impact factor: 2.742

Review 6.  The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis.

Authors:  Mubing Duan; Margaret L Hibbs; Weisan Chen
Journal:  Immunol Cell Biol       Date:  2016-09-27       Impact factor: 5.126

Review 7.  Influenza virus replication in macrophages: balancing protection and pathogenesis.

Authors:  Troy D Cline; Donald Beck; Elizabeth Bianchini
Journal:  J Gen Virol       Date:  2017-09-08       Impact factor: 3.891

8.  Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection.

Authors:  Bibo Zhu; Yue Wu; Su Huang; Ruixuan Zhang; Young Min Son; Chaofan Li; In Su Cheon; Xiaochen Gao; Min Wang; Yao Chen; Xian Zhou; Quynh Nguyen; Anthony T Phan; Supriya Behl; M Mark Taketo; Matthias Mack; Virginia S Shapiro; Hu Zeng; Hideki Ebihara; John J Mullon; Eric S Edell; Janani S Reisenauer; Nadir Demirel; Ryan M Kern; Rana Chakraborty; Weiguo Cui; Mark H Kaplan; Xiaobo Zhou; Ananda W Goldrath; Jie Sun
Journal:  Immunity       Date:  2021-05-04       Impact factor: 43.474

9.  Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus.

Authors:  Yinghua Li; Zhengfang Lin; Min Guo; Yu Xia; Mingqi Zhao; Changbing Wang; Tiantian Xu; Tianfeng Chen; Bing Zhu
Journal:  Int J Nanomedicine       Date:  2017-08-09

10.  IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.

Authors:  Tina Meischel; Svenja Fritzlar; Fernando Villalon-Letelier; Melkamu B Tessema; Andrew G Brooks; Patrick C Reading; Sarah L Londrigan
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.